This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Lars Taavola
Vice President, Chief Intellectual Property Counsel at Mallinckrodt Pharmaceuticals, USA

Agenda Sessions

How and why clinical disclosure teams need to interact with their company’s patent attorneys
May 10, 8:20am
View Session

Speakers at this event

Jessica Valencia

Operational Excellence Expert

Novartis, USA

Lars TaavolaVice President, Chief Intellectual Property Counsel at Mallinckrodt Pharmaceuticals, USA

Agenda Sessions

Speakers at this event

See Lars Speak

Lars Taavola
Vice President, Chief Intellectual Property Counsel at Mallinckrodt Pharmaceuticals, USA